NMDAR-Antibody Encephalitis: A new clinical way to identify patients
21 February 2019
Paper published in Lancet Psychiatry may help with the accurate detection of this form of autoimmune encephalitis
New research to investigate role of blood-brain barrier in neurological conditions
12 February 2019
A new consortium of 27 partners coordinated by our department will tackle the challenge of discovery and characterisation of blood-brain barrier targets and transport mechanisms for brain delivery of therapeutics to treat neurodegenerative and metabolic diseases.
Natural Killer cells used to treat chronic pain
1 February 2019
Damage to nerves during surgery or after an injury can lead to long-term pain. Scientists have found that specialised cells help to remove damaged nerve fibres, allowing new healthy nerves to re-grow, ameliorating nerve pain.
Discussing autoimmune encephalitis research and treatment
19 December 2018
Clinical Neurology Public engagement
Patients, carers, clinicians and scientists get together to talk about this condition
World’s largest autism grant will transform research landscape
26 October 2018
The largest research grant ever given for neurodevelopmental conditions has been awarded by the Innovative Medicines Initiative to an international consortium academically led by the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London.
Prestigious Zülch Prize for Angela Vincent
17 September 2018
The 2018 Zülch Prize honours research into autoimmunity in neurological diseases. Angela Vincent shares the award with Jerome Posner and Josep Dalmau.
NDCN research underpins new European licence for migraine prevention drug
31 July 2018
Novartis receives European licence for Aimovig® (erenumab), the first treatment designed specifically for the prevention of migraine
Change blindness work presented at Digital Humanities Summer School
30 July 2018
Chrystalina Antoniades of the NeuroMetrology Lab delivered a session to these summer school delegates about her work on change blindness with the Ashmolean.
Study identifies biomarker for the diagnosis of Amyotrophic Lateral Sclerosis (ALS)
27 June 2018
Our Department collaborated with Oxford BioDynamics and Massachusetts General Hospital, Harvard Medical School.
Neurology features in BBC programme about the JR Hospital
21 June 2018
Clinical Neurology Public engagement
Aarti Jagannath presents the first in a new series about how the NHS changed our world
Oxford Centre for Neuroinflammation Launched
30 May 2018
We are delighted to announce the launch of the new Oxford Centre for Neuroinflammation (OCNI), which aims to shed light on the causes of neurodegenerative diseases and uncover new treatment pathways.
New Fellows of the Academy of Medical Sciences
10 May 2018
We are delighted to announce that David Beeson, Professor in Molecular Neurosciences, and Robert MacLaren, Professor of Ophthalmology, have been elected Fellows of the Academy of Medical Sciences.
Spot the difference
9 February 2018
Clinical Neurology Publication Research
Remember trying to spot the subtle differences between pictures as a child? It kept us quiet for hours! Neuroscientists including Chrystalina Antoniades have been working with staff at Oxford’s Ashmolean Museum on some interesting ‘spot the difference’ experiments, to try and find out more about how we perceive things.
Encephalitis Research Engagement Day
23 November 2017
Clinical Neurology Public engagement
On 14 November, NDCN's Autoimmune Neurology Group held an event for patients and public, to discuss the research on autoimmune encephalitis at the University of Oxford.
Trench Foot discovery paves way for new treatment
10 October 2017
A team including Professor David Bennett has uncovered the physical cause of trench foot more than 100 years after the painful and debilitating condition was first identified in the First World War.